It is hard to say. It has been used in compassionate use
It is hard to say. It has been used in compassionate use for advanced COVID19 and an Ebola trial. It is hard to pick out the side effects of the drug versus the gruesome diseases. Hepatic toxicity concerns have been mentioned..There were some healthy human volunteers included in the Ebola study. No results were posted including AE or SAE on clinicaltrials.govBelow is a blip which mentions the Phase 1 study where Remdesivir" doses" were safely administered"
"Clinical safety profile from > 100 human subjects dosed with intravenous remdesivir supports the clinical dosing regimen recommended for the treatment of Ebola. Single and repeated doses of remdesivir were safely administered in Phase 1 studies in healthy human subjects, PREVAIL IVstudy in male Ebola virus disease (EVD) survivors, as well as during compassionateuse for the treatment and post exposure prophylaxis ofEbola infection.
That is all I could dig out. I will try to take another look for it later.
Good luck,Farrell
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Market Challenges and Stock Performance Fox Factory Holding Corp (NASDAQ: FOXF) has recently seen its stock sink to a 52-week low, reaching $28.92. This downturn reflects the challenging market conditions the company is currently facing. With a market capitalization of $1.2 billion and a price-to-earnings (P/E) ratio of 113, FOXF now trades below its fair value. Over the...
Continue Reading
Entropy Robotics Partners with SRI for Innovative Navigation Entropy Robotics, an innovative startup focused on AI-driven solutions for robotics and drones, has recently formed a strategic partnership with SRI, an independent nonprofit research organization. This collaboration aims to enhance autonomous navigation capabilities for robots operating in challenging...
Continue Reading
Investment Legal Options for Quanex Building Products Corporation Bronstein, Gewirtz & Grossman, LLC, a leading law firm in investor representation, has announced a significant opportunity for shareholders of Quanex Building Products Corporation (NYSE: NX). Investors who have incurred considerable losses are being invited to participate and potentially lead a class action...
Continue Reading
Braskem's Innovative Sustainability Effort Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK) has launched an exciting new sustainable product—bio-circular polypropylene (PP), known as WENEW. As the top producer of polyolefins in the Americas, Braskem is raising the bar by offering this eco-friendly solution specifically designed for the restaurant and snack food...
Continue Reading
Understanding Direxion Daily Semiconductor Bull 3X Shares Direxion Daily Semiconductor Bull 3X Shares (NYSE: SOXL) has delivered impressive returns over the past 15 years, outperforming the general market by a remarkable 29.99% on an annualized basis. The fund boasts an average annual return of 41.86%, showcasing its strength in the technology sector, which continues to...
Continue Reading
